PSTI - Pluristem Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-2,847379
Cost of Revenue-10013
Gross Profit-2,747366
Operating Expenses
Research Development21,09219,58019,173
Selling General and Administrative6,9276,4866,460
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-28,019-23,319-25,267
Income from Continuing Operations
Total Other Income/Expenses Net20573590
Earnings Before Interest and Taxes-27,814-23,246-24,677
Interest Expense---
Income Before Tax-27,814-23,246-24,677
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-27,814-23,246-24,677
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-27,814-23,246-24,677
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-27,814-23,246-24,677